Comparison of clinical manifestations in mpox patients living with HIV versus without HIV: A systematic review and meta‐analysis
- 10 April 2023
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 95 (4) , e28713
Abstract
Currently, many cases of mpox patients living with the human immunodeficiency virus (HIV) have been reported. Immunocompromised mpox patients, including those living with HIV are noted for an increased risk for severe symptoms; however, existing studies did not focus on the statistical comparison of mpox outcomes associated with HIV. Thus, we conducted a systematic review and meta‐analysis to evaluate and compare the clinical manifestations of mpox in people living with HIV (PLWH) and people without HIV. In this systematic review and meta‐analysis, PubMed/MEDLINE, Embase, and Google Scholar were searched up to March 7, 2023. A random effects model was used to calculate the pooled prevalence along with the 95% confidence intervals (CI), and the odds ratio and its corresponding 95% CIs were calculated to elucidate the significance of each clinical feature for mpox patients with and without HIV. In this study, we included 99 published papers with 2413 patients with mpox (median age, 35.5 years; PLWH n = 1151) from 27 countries across six continents. The odds ratio of the mpox outcomes with PLWH in comparison to patients without HIV was found to be significant for skin rash (1.24, 95% CI: 1.01–1.53), proctitis (2.03, 95% CI: 1.36–3.04), cough (0.57, 95% CI: 0.33–0.98), and diarrhea (3.85, 95% CI: 1.24–11.98). The odds ratio of mpox patients with HIV for historical infections of syphilis was 2.14 (95% CI: 1.38–3.32), compared with those without HIV. This is the first international and comprehensive study that performed a systematic review and meta‐analysis to statistically measure mpox manifestations according to HIV status. As clinical features related to mucosal contact were characteristically pronounced in PLWH, our systematic review provides insight that the primary invasion site of infection strongly relates to the outcomes of mpox.Keywords
Funding Information
- Korea Health Industry Development Institute
This publication has 113 references indexed in Scilit:
- Clinical features and management of human monkeypox: a retrospective observational study in the UKThe Lancet Infectious Diseases, 2022
- Brief Report: Syphilis Incidence and Effect on Viral Load, CD4, and CD4/CD8 Ratio in a Thai Cohort of Predominantly Men Who Have Sex With Men Living With HIVJAIDS Journal of Acquired Immune Deficiency Syndromes, 2021
- Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and EvolutionViruses, 2020
- A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya virusesNature Communications, 2018
- The rectal mucosa and condomless receptive anal intercourse in HIV-negative MSM: implications for HIV transmission and preventionMucosal Immunology, 2017
- HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic InflammationFrontiers in Immunology, 2017
- Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus–Infected Individuals Receiving Suppressive Antiretroviral TherapyThe Journal of Infectious Diseases, 2017
- Preferential Replication of Vaccinia Virus in the Ovaries is Independent of Immune Regulation Through IL-10 and TGF-βViral Immunology, 2011
- Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of CongoProceedings of the National Academy of Sciences, 2010
- Immunobiology of Mucosal HIV Infection and the Basis for Development of a New Generation of Mucosal AIDS VaccinesImmunity, 2004